期刊文献+

超级干扰素抑制A549增殖诱导其衰老 被引量:1

Super Interferon alpha Surpress the Proliferation of A549 Cells and Induce Cellular Senescence
原文传递
导出
摘要 该研究利用MTT和结晶紫的方法证明sIFNα对肺癌细胞A549增殖有很强的抑制作用,而同样剂量的普通干扰素IFNα2b抑制作用要小很多。与对照组相比,sIFNα处理后,细胞形态发生改变,细胞体积变大,形态呈扁平状;Hoechst33258染色发现,细胞核形态无变化并且未检测到凋亡;SA-β-gal染色发现大多数细胞呈现阳性,同时,衰老相关蛋白p53和p21表达量明显上调。而IFNα2b处理组细胞形态基本没有变化,SA-β-gal染色也只有少部分的细胞呈现弱阳性。由此说明,sIFNα比IFNα2b能更好地抑制癌细胞增殖,其机制可能为诱导癌细胞发生衰老。 In this study,the anti-proliferation effect of sIFNαwas tested via the MTT assay and crystal violet staining assay.The results showed that sIFNαhad a strong anticancer effect while IFNα2b had a limited effect. After treated with sIFNα,cells possessed enlarged cell size and flatted morphologic and without nucleus morphologic alteration by Hoechst 33258 staining,and there was no detection of apoptosis.At the same time,most of sIFNα-treated cells exhibited SA-β-gal positive and with the up-expression of p53 and p21.However,cells treated with IFNα2b had little or no changes and few of them were SA-β-gal positive.In conclusion,compared with IFNα2b,sIFNαexerted a potent antineoplastic effect and the mechanism might be related to its induction of cellular senescence.
出处 《中国细胞生物学学报》 CAS CSCD 2011年第5期473-478,共6页 Chinese Journal of Cell Biology
基金 国家自然科学基金(No.30623003) 国家重点基础研究发展规划(973计划)(No.2010CB529901) 国家科技重大专项(重大新药创制)(No.2009ZX09102-246) 国家高技术研究发展计划(863计划)(No.2007AA021006和2007AA02Z156) 国家科技重大专项(No.2008ZX10002-023) 中国科学院知识创新工程重要方向项目(No.KSCX2-YW-R-219) 国家自然科学基金(No.30772521)资助项~~
关键词 干扰素 衰老 抗癌 肺癌 增殖 interferon senescence anti-tumor lung carcinoma proliferation
  • 相关文献

参考文献24

  • 1Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58(2): 71-96.
  • 2Phatak P, Burger AM. Telomerase and its potential for therapeutic intervention. Br J Pharmaco12007; 152(7): 1003 - 11.
  • 3Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130(2): 223-33.
  • 4Homsby PJ. Senescence as an anticancer mechanism. J Clin Oncol 2007; 25(14): 1852-7.
  • 5Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
  • 6Itahana K, Campisi J, Dimri GE Methods to detect biomarkers of cellular senescence: The senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371: 21-31.
  • 7Lloyd AC. Limits to lifespan. Nat Cell Biol 2002; 4(2): E25-7.
  • 8Serrano M. Cancer: A lower bar for senescence. Nature 2010; 464(7287): 363-4.
  • 9lsaacs A, Lindenmann J. Virus interference. 1. The interferon. Proc R Soc Lond B Biol Sci 1957; 147(927): 258-67.
  • 10Pestka S. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 2007; 282(28): 20047-51.

二级参考文献27

  • 1肖永胜,周俭,汤钊猷,樊嘉,吴志全,刘银坤,叶胜龙,沈早卓,薛琼,赵燕.干扰素诱导人肝细胞癌胸苷磷酸化酶表达和拮抗血管生成的实验研究[J].中华医学杂志,2005,85(45):3205-3209. 被引量:6
  • 2孟洁,郎荣刚,范宇,付丽.年轻乳腺癌患者的病理学和生物学特征及其与预后的关系[J].中华肿瘤杂志,2007,29(4):284-288. 被引量:29
  • 3Koyama S, Koike N, Adachi S. Expression of TNF - related apoptosis - inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor - infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor [J]. J Cancer Res Clin Oncol, 2002, 128 (2) : 73 - 79.
  • 4Munoz N, Bosch FX, Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer [J]. N Engl J Med, 2003, 348(6) : 518 - 527.
  • 5Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia [J]. Cancer Invest, 2002, 20(7-8): 1080-1085.
  • 6Bosch FX, Munoz N.The viral etiology of cervical cancer [J]. Virus Res, 2002, 89(2) : 183 - 190.
  • 7Yamakawa Y, Forslund O, Teshima H, et al. Human papilloma virus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction [J]. Gynecol Oncol, 1994, 53(2) : 190 - 195.
  • 8Stark GR, Kerr IM, Williams BRG, et al. How cells respond to interferons [J]. Annu Rev Biochem, 1998, 67(1): 227- 264.
  • 9Lim R, Knight B, Patel K, et al. Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo [J]. Hepatology, 2006, 43(5):1074- 1083.
  • 10Wiest R, Das S, Cadelina G, et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular Contractility [J]. J Clin Invest, 1999, 104(9) : 1223 - 1233.

共引文献5

同被引文献21

  • 1Entchev E V, Schwabedissen A, Gonzalez-Gaitan M. Gradient formation of the TGF-beta homolog Dpp[J]. Cell, 2000, 103(6)I 981-991.
  • 2Elahi M, Rakhshan V, Ghasemian N T, et al. Prognos- tic value of transforming growth factor beta 1 [TGF-be-tall and matrix metalloproteinase 9 [MMP 9] in oral squamous cell carcinoma[J]. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 2012, 17(1) : 21-27.
  • 3Gomes L R, Terra L F, Wailemann R A, et al. TGF- beta1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and F.RK1/2 in highly invasive breast Cancer cells[J]. BMC Cancer, 2012, 12.. 26.
  • 4Imamura T, Hikita A, Inoue Y. The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis [J]. Breast Cancer, 2012, 19(2): 118-124.
  • 5Lampropoulos P, ZizkSermpetzoglou A, Rizos S, et al. Prognostic significance of transforming growth factor beta (TGF-beta) signaling axis molecules and E-cadher- in in colorectal cancer[J]. Tumour Biology, 2012, 33 (4) : 1005-1014.
  • 6Kyprianou N. Activation of TGF beta signalling in hu- man prostate cancer ceils suppresses tumorigenicity via deregulation of cell cycle progression and induction of caspase-1 mediated apoptosis: significance in prostate tumorigenesis[J]. Prostate Cancer and Prostatic Disea- ses, 1999, 2($3): $18.
  • 7Li X, Sterling J A, Fan K H, et al. Loss of TGF-beta responsiveness in prostate stromal cells alters chemo- kine levels and facilitates the development of mixed os- teoblastic/osteolytic bone lesions[J]. Molecular Cancer Research : MCR, 2012, 10(4).. 494-503.
  • 8Mascareno E J, Belashov I, Siddiqui M A, et al. Hexim-1 modulates androgen receptor and the TGF-be- ta signaling during the progression of prostate cancer [J]. The Prostate, 2012, 72(9).. 1035-1044.
  • 9Hirota M, Watanabe K, Hamada S, et al. Smad2 func- tions as a co-activator of canonical Wnt/beta-catenin sig- naling pathway independent of Smad4 through histone aeetyltransferase activity of p3OO[J]. Cellular Signal- ling, 2008, 20(9): 1632-1641.
  • 10Scheel C, Eaton E N, Li S H, et al. Paracrine and au tocrine signals induce and maintain mesenchymal and stem cell states in the breast[J]. Cell, 2011, 145(6).. 926-940.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部